ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ASRT Assertio Holdings Inc

0.6817
-0.0282 (-3.97%)
21 Mar 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Assertio Holdings Inc NASDAQ:ASRT NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0282 -3.97% 0.6817 0.6817 0.78 0.7275 0.71 0.7188 527,218 04:00:05

Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024

11/10/2024 1:00pm

GlobeNewswire Inc.


Assertio (NASDAQ:ASRT)
Historical Stock Chart


From Sep 2024 to Mar 2025

Click Here for more Assertio Charts.

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Brendan O’Grady, Chief Executive Officer, will participate in a fireside chat discussion as part of the Maxim Group 2024 Healthcare Virtual Summit. The fireside chat with Mr. O’Grady, hosted by Maxim Group research analyst Naz Rahman, will occur Tuesday, October 15, 2024 at 1:00 pm Eastern Time.

Investors can register to listen to the event via https://m-vest.com/events/healthcare-10152024.

About Assertio

Assertio is a commercial pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com.

Investor Contact

Matt Kreps, Managing DirectorDarrow AssociatesM: 214-597-8200mkreps@darrowir.com

1 Year Assertio Chart

1 Year Assertio Chart

1 Month Assertio Chart

1 Month Assertio Chart